“Development and industrialization of plasma microRNA-based nucleic acid diagnostic kits for hepatocellular carcinoma markers, a sub-theme of the National 12th Five-Year Plan-2013 Major National Science and Technology Projects "Prevention and Treatment of Major Infectious Diseases such as HIV/AIDS and Viral Hepatitis" (No. 2013ZX10002007).

Establishing a new miRNA-CTC-ctDNA tumor liquid biopsy technology integrating artificial intelligence and a standardized testing platform for the whole chain of liquid biopsy of tumors, as a sub-topic of "Research on the development and evaluation of liquid biopsy-based screening and early diagnosis of common malignant tumors" (Topic No. 2019YFC1315800) of the Key Research and Development Program of the Ministry of Science and Technology of the People's Republic of China in 2019 (Key Special Project on the Research on Prevention and Control of Major Chronic Non-Communicable Diseases)

Health Management Association of Chinese Medical Association - Research on clinical application project.

Shanghai Innovation Cluster - research and development of new technology for diagnosis and treatment of malignant tumors of digestive system and application of precision intervention.

Science and Technology Commission of Shanghai Municipality (STCSM) - development project of fully automatic testing and analysis system for circulating tumor cells.

Science and Technology Commission of Shanghai Municipality (STCSM)- testing of circulating markers based on blood samples of liver malignant tumors.

Science and Technology Commission of Shanghai Municipality (STCSM) “Technology and Innovation Cooperation Action Plan” - technological innovation project for scientific and technological small and medium-sized enterprises.

Shanghai Science and Technology Support Project in the field of biomedicine.

Pujiang Talent Program - clinical research of circulating tumor cells and circulating free DNA combined with next-generation sequencing technology in tumor individualized medical treatment.

Minhang District Economic Commission Project - R & D and commercialization of cancer diagnostic reagents based on microRNA molecular testing platform.

Provide research on biomarkers related to tumor immunotherapy drugs (PD-1/PD-L1 antibody) for many well-known pharmaceutical manufacturers in China.